Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

38.74
+0.68001.79%
Volume:181.14K
Turnover:6.94M
Market Cap:261.50M
PE:- -
High:38.92
Open:38.35
Low:38.07
Close:38.06
52wk High:41.49
52wk Low:22.33
Shares:6.75M
Float Shares:6.75M
Volume Ratio:1.14
T/O Rate:2.68%
Dividend:0.28
Dividend Rate:0.73%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

GlobeNewswire
·
Sep 08

Press Release: Waterdrop Inc. Announces Second Quarter 2026 Unaudited Financial Results and a Cash Dividend

Dow Jones
·
Sep 08

Upstream Bio presents results from VALIANT trial at ERS Congress

TIPRANKS
·
Sep 08

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

GlobeNewswire
·
Sep 08

The Second Act of Biotech

TIPRANKS
·
Sep 07

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Reuters
·
Sep 04

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

TIPRANKS
·
Sep 04

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Dow Jones
·
Sep 03

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

TIPRANKS
·
Sep 03

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live
·
Sep 03

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

Reuters
·
Sep 03

Poolbeg Pharma to spotlight POLB 001 at global scientific and investor conferences

TIPRANKS
·
Sep 03

Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target

TIPRANKS
·
Sep 03

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
Sep 03